End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
808 KRW | +5.76% | +6.04% | +37.18% |
2022 | StemLab Inc. announced that it has received KRW 1.5000006 billion in funding | CI |
2022 | StemLab Inc. announced that it expects to receive KRW 1.5000006 billion in funding | CI |
Business Summary
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Stem Cell Culture Solution
100.0
%
| - | - | 438 | 100.0 % | - |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
100.0
%
| 231 | 100.0 % | 438 | 100.0 % | +89.66% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Donghoon Oh
CEO | Chief Executive Officer | 61 | - |
Jong-Seong Choi
CEO | Chief Executive Officer | 60 | - |
Seung-Kwon Yoo
PSD | President | 59 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Joon Chung
BRD | Director/Board Member | 60 | - |
Jong-Seong Choi
CEO | Chief Executive Officer | 60 | - |
Donghoon Oh
CEO | Chief Executive Officer | 61 | - |
Seung-Kwon Yoo
PSD | President | 59 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 10,378,119 | 2,031,023 ( 19.57 %) | 595,349 ( 5.737 %) | 19.57 % |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+37.18% | 2.92M | |
-2.10% | 90.02B | |
-0.66% | 39.15B | |
-15.83% | 31.71B | |
+62.42% | 26.47B | |
-21.68% | 14.34B | |
-8.73% | 12.89B | |
-10.32% | 11.18B | |
-45.77% | 10.97B | |
+3.45% | 8.94B |
- Stock Market
- Equities
- A258540 Stock
- Company SL Therapeutics, Inc.